Drugs / AMG 745
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00975104 | Apr 2010 → May 2011 | muscular atrophy | Amgen | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 745 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00975104 ↗ |
| Route | Intravenous | “AMG 745 0.3 mg/kg IV QW” NCT00975104 ↗ |